EUVIMEDEUVIMED entdecken
Crossref

Regulatory T‐Cell Dynamics During and After Direct Acting Antivirals in Cirrhotic HCV Genotype 4 Patients

Riham Soliman iD, Douaa Sayed iD, Ayman A Hassan iD, Nabiel N H Mikhail iD, Ahmed Nabil iD, Nada El-Domiaty iD, Gamal Shiha iD

Journal of Viral Hepatitis · 2026-12 · 33 (12)

DOI: 10.1111/jvh.70273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, online erschienen am 15.11.2026. Verfasst von Riham Soliman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Egyptian Liver Research Institute and Hospital (ELRIAH), El Mansoura, Egypt. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Antiviral Agents, Liver Cirrhosis, Hepatitis C, Chronic. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We previously conducted longitudinal immunological studies in non‐cirrhotic chronic hepatitis C patients treated with direct‐acting antivirals (DAAs). However, whether cirrhosis alters these immunological dynamics remains unclear. We aimed to characterize regulatory T cells in HCV cirrhotic patients and evaluate their longitudinal changes during and following successful antiviral therapy in HCV cirrhotic patients. Fifty cirrhotic HCV genotype 4 patients and fifty age‐matched healthy controls were enrolled. Peripheral blood mononuclear cells were analysed at baseline, week 4, end of treatment, and 1 year post‐SVR using multicolour flow cytometry to quantify CD3 + , CD4 + , CD8 + , PD‐1 + , and CD38 + exhausted/activated CD8 + T cells, TH1, TH2, TH17 subsets, and CD4 + CD25 + FoxP3 + regulatory T cells (Tregs). Longitudinal changes were assessed using linear mixed‐effects models with FDR correction. At baseline, cirrhotic patients demonstrated marked immune dysregulation versus controls, with reduced CD3 + T cells, profound CD8 + T‐cell exhaustion (PD‐1 + 71.0% vs. 11.1%; p < 0.001), elevated CD38 + activation, depleted TH1 cells, and significant expansion of TH17 (25.8% vs. 14.0%; p < 0.001) and Tregs (52.7% vs. 15.1%; p < 0.001). Exhausted PD‐1 + CD8 + cells declined by 66.2% at 1 year ( q < 0.001), CD38 + CD8 + cells decreased by 31.3% ( q < 0.001), and Tregs normalized (52.7%–9.6%; q < 0.001). TH1 and TH2 subsets increased, TH17 declined, and total CD3 + /CD4 + T cells rose significantly by 1 year. In this single‐centre cohort of compensated genotype 4 HCV‐related cirrhosis, successful DAA therapy was associated with changes in circulating T‐cell phenotypes, including reductions in Tregs, TH17 cells, and PD‐1/CD38‐expressing CD8+ T cells. These findings suggest partial improvement in peripheral immune dysregulation after viral clearance, but require confirmation in larger multicentre studies with functional assays and longer follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryAntiviral AgentsLiver CirrhosisHepatitis C, ChronicHepacivirusHumansMaleMiddle AgedFemaleGenotypeAdultT-Cell ExhaustionSustained Virologic ResponseFlow CytometryT-Lymphocyte SubsetsLongitudinal StudiesAged

Stichwörter der Autor:innen

HCV cirrhosisT cell exhaustionregulatory T cellssustained virological response

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Egyptian Liver Research Institute and Hospital (ELRIAH), El Mansoura, Egypt.
  • Technical Institute of Nusring, Sherbin, Egypt.
  • Clinical Pathology Department, Faculty of Medicine, Suez University, Suez, Egypt.
  • Medical Laboratories Department, Higher Technological Institute of Applied Health Sciences, Mansoura, Egypt.
  • Biostatistics and Cancer Epidemiology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
  • Biotechnology and Life Sciences Department, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef University, Beni-Suef, Egypt.

ORCID-Profile: Riham Soliman, Douaa Sayed, Ayman A Hassan, Nabiel N H Mikhail, Ahmed Nabil, Nada El-Domiaty, Gamal Shiha

Zitieren

APA

Soliman, R., Sayed, D., Hassan, A. A., Mikhail, N. N. H., Nabil, A., El-Domiaty, N., & Shiha, G. (2026). Regulatory T‐Cell Dynamics During and After Direct Acting Antivirals in Cirrhotic HCV Genotype 4 Patients. Journal of Viral Hepatitis, 33(12). https://doi.org/10.1111/jvh.70273

Vancouver

Soliman R, Sayed D, Hassan AA, Mikhail NNH, Nabil A, El-Domiaty N, et al. Regulatory T‐Cell Dynamics During and After Direct Acting Antivirals in Cirrhotic HCV Genotype 4 Patients. Journal of Viral Hepatitis. 2026;33(12). doi:10.1111/jvh.70273

BibTeX
@article{Soliman2026,
  author = {Soliman, Riham and Sayed, Douaa and Hassan, Ayman A and Mikhail, Nabiel N H and Nabil, Ahmed and El-Domiaty, Nada and Shiha, Gamal},
  title = {Regulatory T‐Cell Dynamics During and After Direct Acting Antivirals in Cirrhotic HCV Genotype 4 Patients},
  journal = {Journal of Viral Hepatitis},
  year = {2026},
  volume = {33},
  number = {12},
  doi = {10.1111/jvh.70273}
}
Kostenlos starten →